These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7514779)

  • 1. Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy.
    Ransom MX; Garcia AJ; Bohrer M; Corsan GH; Kemmann E
    Obstet Gynecol; 1994 Jun; 83(6):1033-7. PubMed ID: 7514779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy.
    Saraj AJ; Wilcox JG; Najmabadi S; Stein SM; Johnson MB; Paulson RJ
    Obstet Gynecol; 1998 Dec; 92(6):989-94. PubMed ID: 9840564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tubal pregnancies: early pregnancy factor, progesterone, beta-HCG and vaginal sonography as differential diagnostic parameters].
    Mesrogli M; Degenhardt F; Maas DH; Klaus I; Busche M; Schneider J
    Z Geburtshilfe Perinatol; 1988; 192(3):130-2. PubMed ID: 2463715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of residual ectopic pregnancy: RU 486 and methotrexate.
    Kenigsberg D; Porte J; Hull M; Spitz IM
    Fertil Steril; 1987 Apr; 47(4):702-3. PubMed ID: 2436953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ectopic pregnancy by transvaginal intratubal methotrexate administration.
    Tulandi T; Bret PM; Atri M; Senterman M
    Obstet Gynecol; 1991 Apr; 77(4):627-30. PubMed ID: 2002990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rising beta-hCG titres following laparoscopic injection of methotrexate into unruptured, viable tubal pregnancies.
    Groutz A; Luxman D; Cohen JR; David MP
    Br J Obstet Gynaecol; 1993 Mar; 100(3):287-8. PubMed ID: 7682841
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of methotrexate treatment failure in ectopic pregnancy.
    Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
    J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
    Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
    Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success.
    Wong L; Fung LWY; Cheung CW; Lao TT
    Int J Gynaecol Obstet; 2018 May; 141(2):245-249. PubMed ID: 29214643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment of ectopic pregnancy by means of a single injection of methotrexate into the gestational sac.
    Venezia R; Zangara C
    Acta Eur Fertil; 1989; 20(4):227-30. PubMed ID: 2485123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of ectopic pregnancy and its effect on corpus luteum activity.
    Shulman A; Maymon R; Zmira N; Lotan M; Holtzinger M; Bahary C
    Gynecol Obstet Invest; 1992; 33(3):161-4. PubMed ID: 1377160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus luteum activity in tubal pregnancy.
    Sauer MV; Gorrill MJ; Rodi IA; Yeko TR; Buster JE
    Obstet Gynecol; 1988 May; 71(5):667-70. PubMed ID: 3357652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of tubal pregnancy with methotrexate.
    Zakut H; Sadan O; Katz A; Dreval D; Bernstein D
    Br J Obstet Gynaecol; 1989 Jun; 96(6):725-8. PubMed ID: 2478186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.
    Lipscomb GH; McCord ML; Stovall TG; Huff G; Portera SG; Ling FW
    N Engl J Med; 1999 Dec; 341(26):1974-8. PubMed ID: 10607814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy.
    Corsan GH; Karacan M; Qasim S; Bohrer MK; Ransom MX; Kemmann E
    Hum Reprod; 1995 Oct; 10(10):2719-22. PubMed ID: 8567799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising human chorionic somatomammotropin predicts ectopic pregnancy rupture following methotrexate chemotherapy.
    Carson SA; Stovall T; Umstot E; Andersen R; Ling F; Buster JE
    Fertil Steril; 1989 Apr; 51(4):593-7. PubMed ID: 2466704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of unruptured tubal pregnancy by local injection of methotrexate under transvaginal sonographic control.
    Ménard A; Créquat J; Mandelbrot L; Hauuy JP; Madelenat P
    Fertil Steril; 1990 Jul; 54(1):47-50. PubMed ID: 1694146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent tubal ectopic gestation: patterns of circulating beta-human chorionic gonadotropin and progesterone, and management options.
    Vermesh M; Silva PD; Sauer MV; Vargyas JM; Lobo RA
    Fertil Steril; 1988 Oct; 50(4):584-8. PubMed ID: 2458973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotrophin in screening for ectopic pregnancy.
    Stovall TG; Ling FW; Andersen RN; Buster JE
    Hum Reprod; 1992 May; 7(5):723-5. PubMed ID: 1379268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic pregnancy: evolution after treatment with transvaginal methotrexate.
    Atri M; Bret PM; Tulandi T; Senterman MK
    Radiology; 1992 Dec; 185(3):749-53. PubMed ID: 1279740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.